More new therapeutic treatments for various diseases could be moved into clinical trials—and potentially faster into mainstream medical use—if scientists could find ways to manufacture exponentially higher quantities of the stem cell components needed for medical testing. Spearheading work to make those cell manufacturing process discoveries is Associate Professor Zhen Ma, the Carol and Samuel Nappi Research Scholar in the College of Engineering and Computer Science. He is working with a newly awarded $500,000 National Science Foundation (NSF) future manufacturing seed grant and coordinating the project with bioengineering experts at the Rochester Institute of Technology (RIT). Read more.